The Tasmanian Heart Failure Project was initiated in February 2016 as a collaboration coordinated by the Australian Healthcare and Hospitals Association, led by Primary Health Tasmania and Heart Foundation Tasmania with support from Novartis Pharmaceuticals Australia and sponsorship from the Tasmanian Department of Health. The vision was to conduct a project to reduce preventable heart failure hospitalisations in Tasmania. The main focus of the project was to support optimal management of heart failure in the primary care setting.
This report has been prepared by the Deeble Institute for Health Policy Research as a final evaluation of the project.
